« Back
Home /
FTC-238 cells

FTC-238 cells

Item no.	C0025001
Manufacturer	Addexbio
Amount	One Frozen vial
Category	Oncology Neuroscience Neural Lineage Markers Metabolism Cholesterol & Lipid Metabolism Molecular Targets for Neuroscience Targets for Rodent Neurosciences Cell Lines & Cell Culture Cell Lines By Organ Lung Cancer Bladder Cancer Thyroid Cancer Astrocyte Markers
Type	Tumour Cells
Specific against	Human (Homo sapiens)
Dry ice	Yes
Citations	1.Song, M., Kim, Y. J., Song, M. K., Choi, H. S., Park, Y., and Ryu, J. C. Identification of Classifiers for Increase or Decrease of Thyroid Peroxidase Activity in the FTC-238/hrTPO Recombinant Cell Line. Environ Sci Technol. 2.Mitmaker, E. J., Griff, N. J., Grogan, R. H., Sarkar, R., Kebebew, E., Duh, Q. Y., Clark, O. H., and Shen, W. T. Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines FTC-238 using demethylating agents and histone deacetylase inhibitors. Surgery, 149: 504-511. 3.Trojanowicz, B., Sekulla, C., Lorenz, K., Kohrle, J., Finke, R., Dralle, H., and Hoang-Vu, C. Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma FTC-238. Mol Cell Endocrinol, 325: 110-117. 4.Stepulak, A., Luksch, H., Gebhardt, C., Uckermann, O., Marzahn, J., Sifringer, M., Rzeski, W., Staufner, C., Brocke, K. S., Turski, L., and Ikonomidou, C. Expression of glutamate receptor subunits in human cancers FTC-238. Histochem Cell Biol, 132: 435-445, 2009. 5.Trojanowicz, B., Winkler, A., Hammje, K., Chen, Z., Sekulla, C., Glanz, D., Schmutzler, C., Mentrup, B., Hombach-Klonisch, S., Klonisch, T., Finke, R., Kohrle, J., Dralle, H., and Hoang-Vu, C. Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines FTC-238. J Mol Endocrinol, 42: 249-260, 2009. 6.Seifert, A., Klonisch, T., Wulfaenger, J., Haag, F., Dralle, H., Langner, J., Hoang-Vu, C., and Kehlen, A. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells FTC-238. Oncol Rep, 19: 1485-1491, 2008.
ECLASS 10.1	32160890
ECLASS 11.0	32160890
UNSPSC	41106509
Available
Description	Disease: Follicular thyroid carcinoma Origin: Established from a lung metastasis of a follicular thyroid carcinoma Species: Homo sapiens Tissue: Thyroid gland Morphology: Polymorphic Properties: Adherent Cytogenic data: Tumorigenic; complex chromosomal changes were detected as well as a p53 mutation Patient: Male, 42 yrs of age Medium: DMEM/F12 + 5% FBS Subculture: 1:10 to 1:20 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: 5' - Deiodinase Type I, p53 mutated Mutations in FTC-238 Cells Related cells by Organ: 8505C cells FTC-238 cells K1 cells
Storage condition	LN2
Manufacturer - Category	Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: One Frozen vial

available

Delivery expected until 1/8/2026

Express Delivery: Save 13 days

Compare

Add to wishlist

Get an offer